# Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease

Study · id `cardio:ct-nct02579499` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02579499](<https://clinicaltrials.gov/study/NCT02579499>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02579499

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 4400 participants.

## Technical summary

Registry record NCT02579499. Randomized; no masking; primary purpose treatment. Start 2016-09-09 (actual); primary completion 2022-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 4400 participants (enrolled count; ClinicalTrials.gov record NCT02579499, source copy `cardio:ctgov-nct02579499-2022-11-30`, retrieved 2026-10-26)
- Started: 2016-09-09 (actual) (ClinicalTrials.gov record NCT02579499, source copy `cardio:ctgov-nct02579499-2022-11-30`, retrieved 2026-10-26)
- Primary completion: 2022-11 (anticipated) (ClinicalTrials.gov record NCT02579499, source copy `cardio:ctgov-nct02579499-2022-11-30`, retrieved 2026-10-26)
- Completion: 2022-11 (anticipated) (ClinicalTrials.gov record NCT02579499, source copy `cardio:ctgov-nct02579499-2022-11-30`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02579499, source copy `cardio:ctgov-nct02579499-2022-11-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02579499-2022-11-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease
- Acronym: LODESTAR
- Condition: Coronary Artery Diseasse
- Intervention (Drug): fixed high potent statin therapy
- Intervention (Drug): targeted LDL-C goal statin
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial (`cardio:pubmed-36877807`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial (`cardio:pubmed-37852649`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Treat-to-target or high-intensity statin treatment in older adults with coronary artery disease: a post hoc analysis of the LODESTAR trial (`cardio:pubmed-38965031`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial (`cardio:pubmed-39113067`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c8ae956546f9fc3345123870c23ab95e1550e42d2723a4e3201f2fd7b1d08177
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
